Open an account

KraneShares MSCI All China Health Care Index ETF

KURE · ETF

$17.85+$0.35 (+2.00%)TodayMarket closed ·
Prev close $17.50

About KURE

KURE was created on 2018-02-01 by KraneShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 115.48m in AUM and 43 holdings. KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector.

Issuer
KraneShares
Tracks
MSCI China All Shares Health Care 10/40 Index
Expense ratio
0.65%
Assets under management
$112.19M
Inception
Feb 1, 2018
Asset class
Equity
Website
kraneshares.com

KURE key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
127.44K
Volume
47.08K
Open price
$17.65
High today
$17.85
Low today
$17.65
52 Week high
$19.93
52 Week low
$14.38

KraneShares MSCI All China Health Care Index ETF (KURE) at a glance

KraneShares MSCI All China Health Care Index ETF (KURE) last traded at $17.85, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $17.65 and $17.85. The current price is 1.1% above the day's low and 0.0% below its high.

Volume so far is 47.08K shares, below the average of 127.44K shares a day.

Over the past year KraneShares MSCI All China Health Care Index ETF has ranged from $14.38 to $19.93, and now sits 63% of the way up that range.

KURE news

  • Rishabh Mishra

    Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'

  • Rishabh Mishra

    Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

  • Rishabh Mishra

    Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

  • Rishabh Mishra

    Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

  • Rishabh Mishra

    Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

  • Surbhi Jain

    China's Market Rebound: Is The NPC Meeting A Turning Point For Investors?

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.